SEK 12.4
(3.33%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 424.18 Thousand EUR | 26.54% |
2022 | 12.4 Million EUR | 47.87% |
2021 | 8.38 Million EUR | 71.29% |
2020 | 4.89 Million EUR | 249.31% |
2019 | 1.4 Million EUR | 37.56% |
2018 | 1.01 Million EUR | 48.14% |
2017 | 687.79 Thousand EUR | 15.17% |
2016 | 597.18 Thousand EUR | 25.99% |
2015 | 473.98 Thousand EUR | 166.66% |
2014 | 177.74 Thousand EUR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 4.05 Million EUR | -36.61% |
2024 Q2 | 4.21 Million EUR | -67.09% |
2023 Q4 | 6.39 Million EUR | 61.97% |
2023 Q1 | 3.62 Million EUR | 19.11% |
2023 Q2 | 3.93 Million EUR | 8.8% |
2023 Q3 | 3.95 Million EUR | 0.27% |
2023 FY | 15.69 Million EUR | 26.54% |
2022 Q3 | 3.36 Million EUR | -0.17% |
2022 Q1 | 2.16 Million EUR | -62.83% |
2022 FY | 12.4 Million EUR | 47.87% |
2022 Q4 | 3.03 Million EUR | -9.59% |
2022 Q2 | 3.36 Million EUR | 55.52% |
2021 Q1 | 1.53 Million EUR | -53.9% |
2021 FY | 8.38 Million EUR | 71.29% |
2021 Q4 | 5.82 Million EUR | 207.52% |
2021 Q3 | 1.89 Million EUR | -36.53% |
2021 Q2 | 2.98 Million EUR | 94.16% |
2020 FY | 4.89 Million EUR | 249.31% |
2020 Q4 | 3.33 Million EUR | 481.9% |
2020 Q3 | 573.16 Thousand EUR | 5.83% |
2020 Q2 | 541.56 Thousand EUR | 22.34% |
2020 Q1 | 442.66 Thousand EUR | 0.0% |
2019 FY | 1.4 Million EUR | 37.56% |
2018 FY | 1.01 Million EUR | 48.14% |
2017 FY | 687.79 Thousand EUR | 15.17% |
2016 FY | 597.18 Thousand EUR | 25.99% |
2015 FY | 473.98 Thousand EUR | 166.66% |
2014 FY | 177.74 Thousand EUR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Aino Health AB (publ) | 13.31 Million SEK | 96.813% |
Bonzun AB (publ) | 5.00 SEK | -8483660.0% |
Kontigo Care AB (publ) | 43.23 Million SEK | 99.019% |
Medhelp Care Aktiebolag (publ) | 100.87 Million SEK | 99.579% |
RaySearch Laboratories AB (publ) | 800.7 Million SEK | 99.947% |
Surgical Science Sweden AB (publ) | 367.6 Million SEK | 99.885% |